These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1208 related items for PubMed ID: 33849479

  • 1. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
    Feng H, Li B, Li Z, Wei Q, Ren L.
    BMC Cancer; 2021 Apr 13; 21(1):401. PubMed ID: 33849479
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ.
    World J Gastroenterol; 2013 Jan 21; 19(3):339-46. PubMed ID: 23372355
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS, Kim DY, Han KH, Kim HS, Shin SH, Jung KS, Kim BK, Kim SU, Park JY, Ahn SH.
    Scand J Gastroenterol; 2016 Mar 21; 51(3):344-53. PubMed ID: 26340708
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.
    Park SJ, Jang JY, Jeong SW, Cho YK, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Park S, Bang HI.
    Medicine (Baltimore); 2017 Mar 21; 96(11):e5811. PubMed ID: 28296720
    [Abstract] [Full Text] [Related]

  • 9. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
    Caviglia GP, Abate ML, Gaia S, Petrini E, Bosco C, Olivero A, Rosso C, Ciancio A, Pellicano R, Saracco GM, Rizzetto M, Smedile A.
    Panminerva Med; 2017 Dec 21; 59(4):283-289. PubMed ID: 28650134
    [Abstract] [Full Text] [Related]

  • 10. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.
    Kim DY, Paik YH, Ahn SH, Youn YJ, Choi JW, Kim JK, Lee KS, Chon CY, Han KH.
    Oncology; 2007 Dec 21; 72 Suppl 1():52-7. PubMed ID: 18087182
    [Abstract] [Full Text] [Related]

  • 11. Comparing prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins glypican-3, Alpha feto protein and carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients.
    Abd El Gawad IA, Mossallam GI, Radwan NH, Elzawahry HM, Elhifnawy NM.
    J Egypt Natl Canc Inst; 2014 Jun 21; 26(2):79-85. PubMed ID: 24841158
    [Abstract] [Full Text] [Related]

  • 12. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
    Viggiani V, Palombi S, Gennarini G, D'Ettorre G, De Vito C, Angeloni A, Frati L, Anastasi E.
    Scand J Gastroenterol; 2016 Oct 21; 51(10):1257-62. PubMed ID: 27227515
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
    Seo SI, Kim HS, Kim WJ, Shin WG, Kim DJ, Kim KH, Jang MK, Lee JH, Kim JS, Kim HY, Kim DJ, Lee MS, Park CK.
    World J Gastroenterol; 2015 Apr 07; 21(13):3928-35. PubMed ID: 25852278
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The value of serum abnormal prothrombin in clinical application of hepatocellular carcinoma].
    Zhang JW, Guan LY, E CY, Yang JH, Xuan W, Meng ZH, Li W.
    Zhonghua Wai Ke Za Zhi; 2020 Oct 01; 58(10):776-781. PubMed ID: 32993265
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
    Jang ES, Jeong SH, Kim JW, Choi YS, Leissner P, Brechot C.
    PLoS One; 2016 Oct 01; 11(3):e0151069. PubMed ID: 26986465
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM, Morsi HK, Abdulateef NA, Noaman MK, Abou El-Ella GA.
    Scand J Clin Lab Invest; 2017 May 01; 77(3):175-183. PubMed ID: 28276727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.